Montecito Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$726K Buy
12,596
+950
+8% +$54.5K 0.11% 165
2026
Q1
$706K Sell
11,646
-610
-5% -$35.6K 0.12% 164
2025
Q4
$661K Sell
12,256
-309
-2% -$14.9K 0.11% 174
2025
Q3
$567K Buy
+12,565
New +$587K 0.09% 198
2025
Q1
$708K Sell
11,604
-620
-5% -$36.1K 0.13% 166
2024
Q4
$691K Hold
12,224
0.12% 168
2024
Q3
$632K Buy
12,224
+323
+3% +$15.2K 0.11% 182
2024
Q2
$494K Sell
11,901
-700
-6% -$31.3K 0.1% 180
2024
Q1
$683K Sell
12,601
-323
-2% -$16.5K 0.14% 149
2023
Q4
$663K Sell
12,924
-6,308
-33% -$331K 0.14% 145
2023
Q3
$1.12M Sell
19,232
-800
-4% -$49K 0.26% 94
2023
Q2
$1.28M Sell
20,032
-639
-3% -$42.8K 0.29% 86
2023
Q1
$1.43M Buy
20,671
+39
+0.2% +$2.75K 0.34% 73
2022
Q4
$1.48M Sell
20,632
-200
-1% -$15.1K 0.36% 74
2022
Q3
$1.48M Hold
20,832
0.39% 64
2022
Q2
$1.6M Buy
20,832
+50
+0.2% +$3.81K 0.38% 62
2022
Q1
$1.52M Sell
20,782
-174
-0.8% -$11.7K 0.28% 80
2021
Q4
$1.31M Sell
20,956
-300
-1% -$17.6K 0.23% 99
2021
Q3
$1.26M Buy
21,256
+1,079
+5% +$71.1K 0.24% 97
2021
Q2
$1.35M Buy
20,177
+580
+3% +$37.8K 0.26% 93
2021
Q1
$1.24M Sell
19,597
-1,617
-8% -$101K 0.26% 89
2020
Q4
$1.32M Sell
21,214
-1,056
-5% -$64.9K 0.29% 81
2020
Q3
$1.34M Buy
22,270
+200
+0.9% +$12K 0.34% 75
2020
Q2
$1.3M Buy
22,070
+689
+3% +$41.2K 0.36% 73
2020
Q1
$1.19M Buy
21,381
+284
+1% +$17.4K 0.39% 65
2019
Q4
$1.35M Buy
21,097
+801
+4% +$45.9K 0.36% 64
2019
Q3
$1.03M Sell
20,296
-481
-2% -$22.6K 0.31% 76
2019
Q2
$943K Sell
20,777
-148
-0.7% -$6.89K 0.28% 82
2019
Q1
$998K Buy
20,925
+2,000
+11% +$99.6K 0.31% 76
2018
Q4
$983K Sell
18,925
-1,586
-8% -$85.2K 0.34% 73
2018
Q3
$1.27M Buy
20,511
+1,525
+8% +$90.5K 0.38% 62
2018
Q2
$1.05M Sell
18,986
-2,906
-13% -$157K 0.34% 63
2018
Q1
$1.38M Buy
21,892
+4,059
+23% +$261K 0.45% 51
2017
Q4
$1.09M Sell
17,833
-1,957
-10% -$122K 0.36% 53
2017
Q3
$1.26M Sell
19,790
-340
-2% -$19.9K 0.44% 41
2017
Q2
$1.12M Buy
+20,130
New +$1.1M 0.4% 48
2017
Q1
Sell
-26,597
Closed -$1.55M 204
2016
Q4
$1.55M Buy
26,597
+582
+2% +$31.8K 0.54% 43
2016
Q3
$1.4M Buy
26,015
+1,600
+7% +$103K 0.58% 47
2016
Q2
$1.79M Buy
24,415
+1,216
+5% +$85.9K 0.76% 28
2016
Q1
$1.48M Buy
23,199
+1,711
+8% +$108K 0.67% 31
2015
Q4
$1.48M Buy
21,488
+9,173
+74% +$606K 0.7% 32
2015
Q3
$729K Sell
12,315
-1,575
-11% -$99.9K 0.4% 50
2015
Q2
$896K Hold
13,890
0.44% 47
2015
Q1
$896K Buy
13,890
+184
+1% +$11.5K 0.44% 47
2014
Q4
$809K Buy
13,706
+103
+0.8% +$5.81K 0.43% 53
2014
Q3
$696K Buy
13,603
+758
+6% +$37.9K 0.42% 51
2014
Q2
$623K Buy
12,845
+706
+6% +$34.8K 0.38% 57
2014
Q1
$630K Buy
12,139
+18
+0.1% +$958 0.4% 54
2013
Q4
$644K Buy
12,121
+52
+0.4% +$2.65K 0.4% 53
2013
Q3
$559K Sell
12,069
-468
-4% -$20.5K 0.37% 58
2013
Q2
$560K Buy
+12,537
New +$544K 0.38% 60

Other funds holding BMY

Montecito Bank & Trust's BMY Position: Q2 2026 in Review

Montecito Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 8.2% in Q2 2026, buying an estimated $54.5K and bringing the position to 12,596 shares worth $726K. The position accounts for 0.11% of the portfolio, ranked #165.

Montecito Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.79M in Q2 2016. 953 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Montecito Bank & Trust held 12,596 shares of Bristol-Myers Squibb worth $726K as of Q2 2026.
  • Montecito Bank & Trust bought 950 Bristol-Myers Squibb shares in Q2 2026, an estimated $54.5K.
  • Bristol-Myers Squibb made up 0.11% of Montecito Bank & Trust's portfolio in Q2 2026, its #165 holding.
  • Montecito Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
  • Montecito Bank & Trust's Bristol-Myers Squibb position peaked at $1.79M in Q2 2016.
  • 953 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.